gfut.txt

Hello Glooko!

 

Working at Glooko has been a real inspiration for me. I’m excited about what’s been accomplished by the team and where we are heading in the future.  

 

As the new Director of Marketing, I’ve had the pleasure of working within the marketing team and cross-departmentally to launch strategic initiatives that further align our mission and vision. As we head into ADA, I’m excited to share with you just a few of the bright points of our efforts to relaunch Glooko as the thought leader in the diabetes data management space.

 

Compelling Glooko Product Offerings

 

Our Comprehensive In-Clinic and Remote Diabetes Management package encompasses our primary and core product to the market. Our intent is to deliver the key programs, analytics, and data sources needed to deliver usable and practical insights for patients and care providers. For clinics, we’ve also aligned our product with their ability to utilize new reimbursement opportunities providing them with the ability to add additional revenue streams.

 

In addition, we’ve defined upsell opportunities providing us the ability to layer in strategic value for clinics and health systems while strengthening our core offering to the market. These additional product offerings are designed to expand our customer's ability to address the unique needs of different patient populations and to further align with their internal goals (i.e., Remote Patient Packages, EHR Integration Suite, Digital Therapeutics and Population Health Analytics).

 

Messaging Strategy

 

We have transitioned focus to align Glooko’s thought leadership narrative with the most important diabetes issues facing the C-Suite. Our messaging strategy includes but is not limited to the following:

 

Position Glooko as a thought leader in diabetes data and insights with a purpose
Communicate and promote Glooko as subject matter experts, with senior leadership and our value propositions to the market
Target C-Suite, clinicians, patients, and the industry
Drive sales targets to contact Glooko for consultation and into sales/marketing strategies
 

In-Market Tactics

 

Relevant content driving thought leadership and lead generation. Here’s what you can expect in the coming days:

 

Glooko.com Refresh
 

Scheduled to launch Friday, June, 7th 2019. The scope of the refresh is focused on clearly articulating our product offerings to the market, support quick decision making and drive a call to action. The Homepage, people with diabetes section and Clinician/Health Systems pages have been redesigned for simplicity, clarity of message and call to action.
This is an intermediate step for us from which we will build out greater contextually relevant materials.
In the Fall, we will complete a global branding project  with the objective being to launch a new globally branded site with both platforms (Glooko & diasend) fully represented under one global branded company-Glooko.
 

All New Sales Enablement Tools and Product Demonstrations
 

Glooko Sales Tool Kit
                                          i.    Corporate Folder (Sales Kit Contents Includes)

                                        ii.    Glooko Corporate Brochure

                                       iii.    Glooko EHR Integration Suite Sales Sheet

                                       iv.    Glooko Mobile Insulin Dosing (MIDS) Sales Sheet

                                        v.    Glooko Remote Monitoring Sales Sheet

                                       vi.    Glooko Mobile App Patient/HCP Sales Sheet

                                      vii.    Glooko Reports Guide

                                    viii.    Glooko Compatibility Guide

 

In addition, we will have Glooko product demonstrations which will be showcased during ADA
                                          i.    Glooko Enterprise - Population Tracker, Report/Graphs and Transmitter

                                        ii.    Glooko Pop Analytics / EHR Integration

                                       iii.    Glooko Mobile Insulin Dosing System (+Dreamed)

                                       iv.    Glooko Product Innovations - Companion Medical InPen (smart-pen integration)

                                        v.    Glooko Mobile App Demo’s

 

Public Relations has been significantly punched up and you will continue to see us expand in this area. The recent news from Glooko includes:
Glooko Names Dr. Mark Clements as New Chief Medical Officer
T1D Exchange Names Glooko as Data Management Partner in Quality Improvement Collaborative
Companion Medical Announces Partnership Agreement with Glooko on Integrated Insulin Data for Multiple Daily Injections
 

Media Interviews at ADA:
MedCity News - Dr. Clements
DiabetesMine  - Dr. Clements
Close Concerns - Dr. Clements
Children with Diabetes - Dr. Clements
Medtech Insight - Russ Johannesson and/or Dr. Clements
Diabetes Technology & Therapeutics - Russ Johannesson and/or Dr. Clements
Diabetes Strong - Russ Johannesson and/or Dr. Clements
Seagrove Partners - Russ Johannesson for the CEO interview series
 

We are excited to kick off the beginning of the new Glooko presence in the market. Please contact me, Russ or Holly if you have any questions or comments.

 

Thank you for your continued support.